Avinger announces conversion of 12% of crg term debt into equity

Redwood city, ca / accesswire / august 4, 2023 / avinger, inc. (nasdaq:avgr), a commercial-stage medical device company developing and marketing the first and only intravascular image-guided, catheter-based systems for diagnosis and treatment of vascular disease, today announced the conversion of approximately 12% of its existing debt with entities affiliated with crg partners iii l.p. ("crg") into shares of a new series of convertible preferred stock.
AVGR Ratings Summary
AVGR Quant Ranking